Allicin, the main organic allyl sulfur component in garlic, exhibits immune-stimulatory and antitumor properties. Allicin stimulated [ 3 H]thymidine incorporation in mouse splenocytes and enhanced cell-mediated cytotoxicity in human peripheral mononuclear cells. Multiple administration (i.p.) of allicin elicited a marked antitumor effect in mice inoculated with B-16 melanoma and MCA-105 ®brosarcoma. The immune-stimulatory and antitumor effects of allicin are characterized by a bell-shaped curve, i.e. allicin at high, supra-optimal concentrations is less effective or inhibitory. Allicin induced activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in human peripheral mononuclear cells, and also in wild-type Jurkat T-cells. Allicin failed to activate ERK1/2 in Jurkat T cells that express p21 ras , in which Cys118 was replaced by Ser. These cells are not susceptible to redox-stress modi®cation and activation. We postulate that the immune stimulatory effect of allicin is mediated by redox-sensitive signaling such as activation of p21 ras . It is suggested that the antitumor effect of allicin is related to its immune-stimulatory properties.
Introduction
It is claimed that garlic is effective against a broad spectrum of diseases. During the past 20 years, studies on garlic have been conducted primarily in the ®eld of cardiovascular and cancer research. It has been suggested that garlic decreases cholesterol and triglyceride levels, and may reduce the atherosclerosis process (1±3). Anti-thrombotic and vasodilatory effects of garlic have also been noted (4, 5) . The in vitro stimulatory effect of garlic extracts on rat and human lymphocytes has been reported (6, 7) . Diallyltrisul®de has been shown to augment concanavalin A activation of T lymphocytes (8) . Garlic extracts have been found to elevate IL-10 and IL-12 in monocytes, while suppressing other proin¯ammatory cytokines, including IL-2 (9) . A protein fraction (F4), isolated from aged garlic extract, enhanced the cytotoxicity of human peripheral blood lymphocytes against NK-sensitive and -resistant cell lines (7) . Aged garlic extracts have an immunomodulatory effect (10) and, upon administration intravesically, were effective against murine transitional cell carcinoma, similar to that of BCG (11) . Both preparations induced lymphocyte and macrophage in®ltration and cytokine release. It is apparent that garlic components induce immune stimulation by mitogenic activation (e.g. allicin) and by providing an adjuvant effect (e.g. protein F4).
Reports have indicated that garlic plays a role in reduction of death caused by malignant diseases (12±14). Garlic constituents were shown to exhibit antitumor and cytotoxic action, both in vitro and in laboratory animals (15±17), and also to possess antibacterial, antifungal and antiparasitic activities (18, 19) . Pre-clinical and clinical studies indicated that agents stimulating the immune system in a non-speci®c manner, exhibit antitumor properties (20±23). Hemin, an iron-containing compound generating free radicals, exhibits immunestimulatory and antitumor properties (24) . We have recently reported (25) that ferrocene, a synthetic iron-containing compound, induces lymphocyte activation and antitumor activity by redox-sensitive signaling.
The organic allyl sulfur components in garlic (mainly allicin) were implicated to mediate its biological activity. It has been suggested that the biological activities of these compounds may be related to their SH modi®cation and antioxidant properties (26±28). The proto-oncogene p21 ras has been identi®ed as a key molecular switch involved in regulating T cell activation, triggered by different mitogens (29±32). We have previously described the immune stimulatory properties of agents that generate free radicals (33±37). We found that p21 ras was a primary target for these agents and have identi®ed a single cysteine residue, Cys118, modi®ed by free radicals (38±40). This modi®cation triggers the activation of p21 ras , mimics the effect of guanosine nucleotide exchange factor, and leads to downstream signaling events such as the activation of mitogen-activated protein kinase, activation of phosphatidylinositol 3¢-kinase and transcription factor activation (41, 42) .
We explored the hypothesis that p21 ras plays a role in mediating the effect of allicin (as a SH modi®er) to induce lymphocyte activation and elicit an antitumor effect.
Methods

Materials
Alliin was synthesized from L-cysteine and allyl bromide after oxidation by H 2 O 2 using the procedure described by Stoll and Seebeck (43) . Pure allicin was produced by applying synthetic allicin into immobilized alliinase (44), followed by its puri®ca-tion according to Jansen et al. (45) . Phytohemagglutinin (PHA) was obtained from Sigma (Rehovot, Israel) and human recombinant IL-2 (2 Q 10 7 U/mg) was obtained from PeproTech (Rocky Hill, NJ).
Jurkat T cells stably expressing p21 ras C118S(1±189)
Jurkat T cells stably expressing p21 ras C118S(1±189), in which Cys118 was replaced by Ser, were prepared as previously described (39, 40) . These transfected cells expressed 7-to 10-fold more p21 ras than the wild-type cells as determined by western blotting with anti-p21 ras antibody, Y13-259, and did not respond to thiol modi®ers by stimulating ERK1/2. This antibody cannot distinguish between wild-type and p21 ras C118S, suggesting that although endogenous p21 ras was not speci®cally inhibited, ectopic expression of high levels of mutant p21 ras apparently prevented its signaling (39) . This dominant-negative activity of p21 ras C118S toward thiol modi®cation may be due to its high level of expression. 
Isolation of cells and culture conditions
Human peripheral blood mononuclear cells (PBMC) were obtained from normal, healthy subjects by Ficoll-Hypaque density gradient centrifugation, and contained 70±90% lymphocytes and 10±30% monocytes. They were suspended (1 Q 10 6 /ml) in RPMI 1640 medium containing 5% FCS and distributed (0.2 ml aliquots) in¯at-bottom microwells, and various additions were made. Cells were then incubated at 37°C in a 95% air, 5% CO 2 atmosphere for the time indicated and [ 3 H]thymidine incorporation (2 mCi/well) into DNA during the ®nal 20 h of incubation was determined. Triplicate cultures were examined and the means T SD were determined.
Mouse splenocytes
Spleens were removed aseptically and crushed in RPMI 1640 supplemented with 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 5 Q 10 ±5 2-mercaptoethanol, 100 mg/ml streptomycin, 100 U/ml penicillin, 0.03% fresh glutamine and 5% heat-inactivated FCS [complete medium (CM)]. Cells were then washed twice with PBS, resuspended in CM (2 Q 10 6 /ml), distributed (0.2 ml aliquots) in¯at-bottomed microwells and incubated at 37°C for the time indicated. [ 3 H]Thymidine incorporation (2 mCi/well) into DNA during the ®nal 20 h of incubation was determined. Triplicate cultures were examined and the means T SD were determined.
In vitro cytotoxicity assay
Cytotoxicity assays were performed as follows: target cells were labeled with 400 mCi of sodium 51 CrO 4 for 1 h in CM. They were then washed 3 times and resuspended in CM at 5 Q 10 6 cells/ml. Effector cells were prepared as above, washed and mixed with target cells at various E:T ratios, and incubated in 96-well, round-bottomed microplates for 3 h at 37°C in a 5% CO 2 incubator. Cell cultures were harvested and supernatants counted in a liquid scintillation counter. Maximum isotope release (MR) was produced by incubation of the targets with 0.1% Triton X-100. Spontaneous release (SR) was measured by incubation of the targets with medium alone. The percentage of cell lysis was calculated by: ER ± SR/MR ± SR Q 100, where ER was the experimental effector release.
Western blot analysis
Cells were solubilized with lysis buffer containing 50 mM Tris± HCl (pH 7.5), 0.5% Triton X-100, 3 mM EGTA, 12 mM bglycerophosphate, 150 mM sodium chloride, 50 mM sodium uoride, 1 mM sodium vanadate, 2 mM DTT, 1 mM PMSF, 1 mM aprotinin and 0.1% 2-mercaptoethanol. Cell lysates were then applied to a 10% polyacrylamide gel. The electrophoresed proteins were transblotted onto a nitrocellulose membrane. After blocking, the membranes were incubated with a mouse monoclonal anti-MAP kinase, activated (diphosphorylated ERK1 and ERK2), clone MAPK-YT (Sigma, St Louis, MO; M-8159). The membrane was then incubated with horseradish peroxidase-conjugated goat anti-mouse antibody and developed with enhanced chemiluminescence mixture. . Cells were incubated for 3±5 (A) and 3 (B) days under conditions that were described in Methods. *P < 0.05, ** P < 0.01, ***P < 0.001 versus cell cultures without allicin. 
Statistical analysis
Results are expressed as means T SD. Differences between means were determined using Student's t-test. (Fig. 1A) . Allicin also stimulates [ 3 H]thymidine incorporation in human PBMC (Fig. 2B ).
Results
Lymphocyte activation induced by allicin
Enhancement of cell-mediated cytotoxicity. Human PBMC incubated for 6 days with allicin elicited cell-mediated cytotoxicity against NK-susceptible human erythroleukemic cells (K562) (Fig. 2A) . Allicin induction of cell-mediated cytotoxicity revealed a`bell-shaped' pattern, i.e. allicin, at high concentrations, was less effective. Allicin further enhanced IL-2-induced cell-mediated cytotoxicity in human PBMC (Fig. 2B) . 
Antitumor properties of allicin
The antitumor effect of allicin was evaluated in mice bearing established lung metastases, following injection of the tumor cells into the tail vein. Mice were sacri®ced 25 days post-tumor inoculation. The weight of lungs in tumor-inoculated mice, above that of controls, represents tumor load. The antitumor effect of allicin in B-16 melanoma bearing mice is shown in Fig. 3(A) . Allicin was administered i.p. at different doses, 4 times each, on days T 2 T 6 T 9 and T 13 (T 0 = day of tumor inoculation). Tumor load was assessed by weighing the lungs at T 25 . Maximal antitumor effect was attained by administration of allicin at multiple doses of 5 mg/ kg, as outlined above. Allicin at higher doses was less or not effective.
The antitumor effect of allicin in MCA-105 ®brosarcoma-bearing mice is shown in Fig. 3(B) . Allicin, at different doses, was administered (i.p.) on days T 2 , T 9 and T 14 . Tumor load was assessed by weighing the lungs 25 days post-tumor inoculation. Maximal antitumor effect was attained by administration of allicin at multiple doses of 12.5 mg/kg as outlined above. Allicin at a higher dose (25 mg/kg) was signi®cantly less effective.
Mechanism of action of allicin
We postulate that p21 ras is a primary molecular target of allicin in stimulating lymphocytes. p21 ras plays a key role in T lymphocyte activation and has previously been shown to be activated by cellular redox stress. ERK1/2, which belong to the mitogen-activated protein kinase family, are downstream of ras and are activated (phosphorylated) by a variety of growth factors. Figure 4(A) demonstrates the activation of ERK1/2 in human PBMC treated with allicin (10 mg/ml). The levels of activated ERK1/2 were determined by western blot analysis at different time intervals following allicin addition, maximal stimulation being attained after 10 min, diminishing gradually with time. Thirty minutes after allicin was added, the level of activated ERK1/2 was similar to that of control, untreated cells. As a positive control, cells were treated with PHA (2 mg/ml) for 10 min. To establish that p21 ras Cys118 is a primary target site for oxidation by allicin, we investigated the stimulatory effect of allicin on ERK1/2 (which is mediated by ras) in wild-type Jurkat T cells and in Jurkat T cells that express p21 ras in which Cys118 was replaced by a Ser residue (referred to as p21 ras C118S, see Methods), which is not susceptible to redox-stress modi®cation. As depicted in Fig. 4(B) , allicin activates ERK1/2 Fig. 4 . Allicin induces activation of ERK1/2 in human PBMC. (A) Human PBMC were suspended (9 Q 10 6 /ml) in RPMI 1640 without serum. After incubation for 2 h at 37°C in a CO 2 incubator, allicin and PHA were added, as indicated. Allicin induces activation of ERK1/2 in Jurkat T cells/wild-type, but not in Jurkat T cells/C118S. (B) Jurkat T cells (2 Q 10 6 /ml) were suspended in RPMI 1640 without serum and incubated for 20 h at 37°C in a CO 2 incubator. Allicin and PHA were added as indicated. At different time intervals, 1-ml aliquots of cell suspension were centrifuged (at 4°C) and 100 ml of lysis buffer was added to the cell pellet. Thirty microliters of the cell lysates was applied for gel electrophoresis. Activated ERK1/2 were demonstrated using western blot analysis, as described in Methods. All experiments depicted in Figs 1±4 were repeated 2±3 times with similar results.
Allicin-induced redox-triggered signaling 279
Downloaded from https://academic.oup.com/intimm/article-abstract/16/2/275/677307 by guest on 02 March 2019 in wild-type Jurkat cells, but failed to do so in Jurkat C118S. On the other hand, PHA, which does not activate p21 ras via redox stress, phosphorylates ERK1/2 in both cells. Levels of activated ERK1/2 in the cell lysates were determined by western blot analysis, using anti-phosphorylated ERK1/2.
Discussion
The many bene®cial effects of garlic have been reported. They include anticancer activity, immunomodulatory effects, antibacterial and antiparasitic effects, and lowering serum cholesterol, triglycerides and blood pressure (3) . It is plausible that the different compounds comprising garlic ingredients are involved in eliciting their multiple effects.
The most characterized non-protein fraction of garlic includes the organosulfur compounds. Allicin is the main biologically active component of this group and its action was attributed to either antioxidant activity or interaction with thiolcontaining proteins. In this paper we reported the immunostimulatory properties of a pure preparation of allicin. In vitro, allicin induced proliferation of both murine splenocytes and human PBMC, enhanced cytotoxicity of human PBMC, and synergized with IL-2 to elicit this effect. Ras is a key element of various signaling pathways, and is implicated in the regulation of proliferation and differentiation by tyrosine kinase and G protein-coupled receptors (46) . We have previously shown that p21 ras is a common signaling target of reactive free radicals and cellular redox stress, and described the immunostimulatory properties of agents that generate free radicals, including iron-containing compounds such as hemin (33±37) and ferrocene (25) .
Allicin activated ERK1/2, which is downstream of ras, in human PBMC and wild-type Jurkat T cells, but failed to do so in Jurkat T cells expressing p21 ras in which Cys118 was replaced by a Ser residue, rendering them not susceptible to redox-stress modi®cation. Redox-stress modulators such as NO, H 2 O 2 , hemin and Hg 2+ were previously reported to activate ras (38) . Our ®ndings suggest that p21 ras is a molecular target of allicin (as a SH modi®er) that along with other sensitive targets induce activation of lymphocytes.
Allicin also has an antitumor effect in mice bearing B-16 melanoma and MCA-105 ®brosarcoma. The antiproliferative and cytotoxic effects of garlic thioallyl derivatives on tumor cell lines in culture has been reported (15±17). We postulated that the in vivo antitumor effect reported here is mediated by immune stimulation. This is supported by our ®ndings demonstrating the immune stimulatory properties of allicin, and the observation that both immune stimulation and the antitumor effect are characterized by a bell-shaped curve, i.e. allicin at high, supra-optimal concentrations is less effective or inhibitory. If, under the experimental conditions employed, allicin had a direct antitumor effect, one would expect a better response at higher concentrations.
In this paper, we propose a molecular mechanism for allicininduced lymphocyte activation which may mediate the antitumor effect of allicin. The basis for this proposal is mainly indirect. A proposed mechanism for allicin activity mediated by a modi®cation of p21 ras cysteine 118 is outlined in Fig. 5 .
Further studies are required to demonstrate the direct modi®cation of p21 ras by allicin, and elucidating the mechanism which couples allicin-induced immune stimulation and its antitumor effect.
It is unlikely that the redox-triggered mechanism of allicin can be extended to all the biological effects attributed to garlic. The different components of garlic may exert their biological effect by various mechanisms.
